Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is PTrana Meditama Metropolitan Tbk OCF Yield %?
PTrana Meditama Metropolitan TbkISX:SAME -0.65%79 OCF Yield % is 6.96 as of Jul. 18, 2026, which is 91% above its 10-year median of 3.65. GuruFocus rates ISX:SAME with a GF Score™ of 79/100 and a GF Value™ of Rp355.17 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 685 Healthcare Providers & Services companies, PTrana Meditama Metropolitan Tbk ranks better than 57.66% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for PTrana Meditama Metropolitan Tbk's OCF Yield % or its related term are showing as below:
ISX:SAME'
s OCF Yield % Range Over the Past 10 Years
Min: -1.26 Med: 3.65 Max: 40.43
Current: 6.96
During the past 13 years, the highest OCF Yield % of PTrana Meditama Metropolitan Tbk was 40.43%. The lowest was -1.26%. And the median was 3.65%.
ISX:SAME's OCF Yield % is ranked better than 57.66% of 685
companies
in the Healthcare Providers & Services industry
Industry Median: 5.44
vs ISX:SAME: 6.96
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
PTrana Meditama Metropolitan Tbk OCF Yield % Related Terms
PTrana Meditama Metropolitan Tbk OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, PTrana Meditama Metropolitan Tbk's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PTrana Meditama Metropolitan Tbk OCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PTrana Meditama Metropolitan Tbk's OCF Yield % distribution charts can be found below:
* The bar in red indicates where PTrana Meditama Metropolitan Tbk's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PTrana Meditama Metropolitan Tbk (ISX:SAME) has a OCF Yield % of 6.96 as of Jul. 18, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on PTrana Meditama Metropolitan Tbk and its competitors. This is 91% above median its historical median of 3.65. According to the industry distribution chart, PTrana Meditama Metropolitan Tbk ranks #290 out of 685 companies in the Healthcare Providers & Services industry, placing it in the top 42.3%.
Is PTrana Meditama Metropolitan Tbk's OCF Yield % too high?
PTrana Meditama Metropolitan Tbk's current OCF Yield % of 6.96 is 91% above median its 10-year median of 3.65. The Healthcare Providers & Services industry median OCF Yield % is 5.44. PTrana Meditama Metropolitan Tbk's value of 6.96 is 27.9% above this industry median. Based on the distribution chart, PTrana Meditama Metropolitan Tbk ranks #290 out of 685 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, PTrana Meditama Metropolitan Tbk has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PTrana Meditama Metropolitan Tbk's OCF Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PTrana Meditama Metropolitan Tbk ranks #290 out of 685 companies for OCF Yield %. This puts PTrana Meditama Metropolitan Tbk in the upper half of its industry. The industry median OCF Yield % is 5.44. PTrana Meditama Metropolitan Tbk's value of 6.96 is 27.9% above this benchmark. While the company's 10-year median is 3.65 vs. the industry median of 5.44, PTrana Meditama Metropolitan Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Healthcare Providers & Services company?
The median OCF Yield % among Healthcare Providers & Services companies is 5.44, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PTrana Meditama Metropolitan Tbk's current OCF Yield % of 6.96 is 27.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on PTrana Meditama Metropolitan Tbk and its competitors. For the Healthcare Providers & Services industry, the median OCF Yield % is 5.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PTrana Meditama Metropolitan Tbk's current OCF Yield % is 6.96, which is 91% above median its own 10-year median of 3.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PTrana Meditama Metropolitan Tbk stock overvalued right now?
Based on GuruFocus' analysis, PTrana Meditama Metropolitan Tbk (ISX:SAME) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp355.17, compared to a current price of Rp306.00 — trading 13.8% below its estimated fair value. The current OCF Yield % is 6.96, which is 91% above median its 10-year median of 3.65 and 27.9% above the Healthcare Providers & Services industry median of 5.44. PTrana Meditama Metropolitan Tbk's overall GF Score™ is 79/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For PTrana Meditama Metropolitan Tbk (ISX:SAME), the current OCF Yield % is 6.96 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PTrana Meditama Metropolitan Tbk (ISX:SAME) Overvalued in 2026?
Based on GuruFocus' analysis, PTrana Meditama Metropolitan Tbk stock appears to be undervalued.
The current stock price of Rp306.00 is trading 13.8% below its estimated GF Value™ of Rp355.17.
GuruFocus considers PTrana Meditama Metropolitan Tbk to be Modestly Undervalued.
Key valuation signals for ISX:SAME:
OCF Yield %: 6.96 (91% above median its 10-year median of 3.65)
GF Value™: Rp355.17 vs. price of Rp306.00 (13.8% below fair value)
Industry Position: 27.9% above the Healthcare Providers & Services median (#290 of 685)
No single metric tells the full story. See the ISX:SAME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PTrana Meditama Metropolitan Tbk Business Description
PT Sarana Meditama Metropolitan Tbk is engaged in managing hospitals. Its hospitals are operated under the brand name Omni Hospital. The company manages and evaluates its business based on its geographic location consisting of Omni Pulomas, Omni Alam Sutera, Omni Cikarang, OMNI Pekayon, and others. It operates in Banten, DKI Jakarta, and West Java.
79GF Score
Get the complete analysis for ISX:SAME
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:SAME has been successfully added to your 
